Millennium Pevonedistat P2001

About this trial

Patient Profile

Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Low-Blast Acute Myelogenous Leukemia

Where’s this trial being run?

Tallaght University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: Millennium Pevonedistat P2001
Number: CTRIAL-IE 16-08
Full Title:

Phase 2, Randomized, Controlled, Open-Label, Clinical Study of the Efficacy and Safety of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Low-Blast Acute Myelogenous Leukemia

Principal Investigator: Helen Enright
Type: Industry Sponsored
Sponsor:

Millenium

Recruitment Started: Global:
Ireland:
Global Recruitment Target: 3000
Ireland Recruitment Target: 6